This Biotech's Never Before Seen Magnetodrones Technology Could Revolutionize Cancer Treatment

Michael Gareau, Chairman of the Board, Founding President & CEO of Starpax Biopharma, was recently interviewed by Benzinga.

Starpax is a biopharma and medtech company that has developed an innovative platform for treating cancer. The company has developed what it calls Magnetodrones, which deliver cancer drugs directly into a tumor. They are self-propelled and do not need to enter the bloodstream. They work in tandem with the Polartrak, a device that keeps the Magnetodrones contained within the tumor.

The company is currently seeking FDA approval for six indications with unmet needs.

Watch the full interview here:

Featured photo by Louis Reed on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.